Robert Millen - Jensen Investment Management Inc
Holding/activity history for Glaxosmithkline PLC Spons ADR (AP47)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2009 Q4 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2009 Q3 | 2,135 | <0.01 | $39.34 | $84,000 | SEC | ||
| 2009 Q2 | 2,135 | <0.01 | $35.13 | $75,000 | SEC | ||
| 2009 Q1 | 2,135 | <0.01 | Reduce 29.65% | <0.01 | $30.91 | $66,000 | SEC |
| 2008 Q4 | 3,035 | <0.01 | Reduce 12.66% | <0.01 | $37.23 | $113,000 | SEC |
| 2008 Q3 | 3,475 | <0.01 | Reduce 10.32% | <0.01 | $43.45 | $151,000 | SEC |
| 2008 Q2 | 3,875 | <0.01 | $44.13 | $171,000 | SEC | ||
| 2008 Q1 | 3,875 | <0.01 | Reduce 9.36% | <0.01 | $42.32 | $164,000 | SEC |
| 2007 Q4 | 4,275 | <0.01 | $50.29 | $215,000 | SEC | ||
| 2007 Q3 | 4,275 | <0.01 | $53.10 | $227,000 | SEC | ||
| 2007 Q2 | 4,275 | <0.01 | $52.40 | $224,000 | SEC | ||
| 2007 Q1 | 4,275 | <0.01 | $55.20 | $236,000 | SEC | ||
| 2006 Q4 | 4,275 | 0.01 | $52.87 | $226,000 | SEC | ||
| 2006 Q3 | 4,275 | 0.01 | $53.33 | $228,000 | SEC | ||
| 2006 Q2 | 4,275 | 0.01 | $55.91 | $239,000 | SEC | ||
| 2006 Q1 | 4,275 | 0.01 | $52.40 | $224,000 | SEC | ||
| 2005 Q4 | 4,275 | 0.01 | Reduce 9.52% | <0.01 | $50.53 | $216,000 | SEC |
| 2005 Q3 | 4,725 | 0.01 | Reduce 1.97% | <0.01 | $51.22 | $242,000 | SEC |
| 2005 Q2 | 4,820 | 0.01 | Reduce 25.02% | <0.01 | $48.55 | $234,000 | SEC |
| 2005 Q1 | 6,428 | 0.01 | Reduce 7.22% | <0.01 | $45.89 | $295,000 | SEC |
| 2004 Q4 | 6,928 | 0.01 | Reduce 45.85% | <0.01 | $47.34 | $328,000 | SEC |
| 2004 Q3 | 12,793 | 0.02 | $43.70 | $559,000 | SEC | ||
| 2004 Q2 | 12,793 | 0.02 | Reduce 0.39% | <0.01 | $41.43 | $530,000 | SEC |
| 2004 Q1 | 12,843 | 0.02 | Reduce 0.77% | <0.01 | $39.94 | $513,000 | SEC |
| 2003 Q4 | 12,943 | 0.03 | Add 15.15% | <0.01 | $46.59 | $603,000 | SEC |
| 2003 Q3 | 11,240 | 0.03 | Reduce 5.86% | <0.01 | $42.44 | $477,000 | SEC |
| 2003 Q2 | 11,940 | 0.03 | Reduce 1.00% | <0.01 | $40.54 | $484,000 | SEC |
| 2003 Q1 | 12,061 | 0.04 | $35,190.03 | $424,427,000 | SEC | ||
| 2002 Q4 | 12,061 | 0.04 | Reduce 13.33% | 0.01 | $37.48 | $452,000 | SEC |
| 2002 Q3 | 13,916 | 0.09 | Add 0.40% | <0.01 | $38,430.01 | $534,792,000 | SEC |
| 2002 Q2 | 13,861 | 0.12 | $43,140.03 | $597,964,000 | SEC | ||
| 2002 Q1 | 13,861 | 0.17 | Reduce 1.42% | <0.01 | $47,000.00 | $651,467,000 | SEC |
| 2001 Q4 | 14,061 | 0.33 | Reduce 1.09% | <0.01 | $49,820.00 | $700,519,000 | SEC |
| 2001 Q3 | 14,216 | 0.55 | Reduce 1.01% | <0.01 | $56,120.01 | $797,802,000 | SEC |
| 2001 Q2 | 14,361 | 0.54 | $56,199.99 | $807,088,000 | SEC | ||
| 2001 Q1 | 14,361 | 0.58 | Add 12.54% | 0.06 | $52,299.98 | $751,080,000 | SEC |
| 2000 Q4 | 12,761 | 0.49 | Reduce 3.59% | 0.02 | $56,000.00 | $714,616,000 | SEC |
| 2000 Q3 | 13,236 | 0.58 | Buy | 0.58 | $60,440.01 | $799,984,000 | SEC |